Linezolid

CHEMBL126 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
337.4 g/mol
LogP
0.7
Phase
4

An oxazolidinone antibiotic used to treat serious gram-positive bacterial infections, including MRSA and vancomycin-resistant enterococci. It works by blocking the early stage of bacterial protein synthesis at the ribosomal level.

Moleküler Ağırlık

337,3500 g/mol

LogP

0,70

TPSA

71,10 Ų

Lipinski RO5

Geçer

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1

InChI

InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1

Molecular Formula

C16H20FN3O4

HBD / HBA

1 / 6

Döndürülebilir Bağlar

4

Ağır Atomlar

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

An oxazolidinone antibiotic used to treat serious gram-positive bacterial infections, including MRSA and vancomycin-resistant enterococci. It works by blocking the early stage of bacterial protein synthesis at the ribosomal level.

Yes, Linezolid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL126. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 441401. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.